Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

Screening for hepatitis C in sexual health clinic attendees

M. Cristina Mapagu A , Sarah J. Martin B C D , Marian J. Currie C and Francis J. Bowden B C
+ Author Affiliations
- Author Affiliations

A Westmead Hospital, PO Box 533, Wentworthville, NSW 2145, Australia.

B Canberra Sexual Health Centre, The Canberra Hospital, PO Box 11, Woden, ACT 2606, Australia.

C Academic Unit of Internal Medicine, Australian National University Medical School, School of Clinical Medicine, The Canberra Hospital, PO Box 11, Woden, ACT 2606, Australia.

D Corresponding author. Email: sarah.martin@act.gov.au

Sexual Health 5(1) 73-76 https://doi.org/10.1071/SH07034
Submitted: 15 May 2007  Accepted: 2 December 2007   Published: 22 February 2008

Abstract

Introduction: Hepatitis C virus (HCV) prevalence has been shown to be higher in some sexual health clinic attendees than the general population. Screening for HCV in sexual health clinics may be based on risk assessment or universal screening. The aim of this audit was to explore the value of routine HCV screening in a sexual health centre population. Methods: Medical records and pathology data concerning all patients tested for HCV between 2000 and 2002 at Canberra Sexual Health Centre were audited to determine whether the diagnosis of HCV was already known and which, if any, risk factors were identified at the time of testing. Results: A total of 3845 tests were conducted on 3156 individuals over the 3-year period. HCV seropositivity was confirmed in 95 patients (3.0%; 95% CI 2.4–3.7), of which 29 (30.5%) were new diagnoses. A total of 85.3% of all patients with confirmed HCV infection reported a history of injecting drug use. Tattoos and body piercings were the most common risk factor in those who denied ever injecting. Risk factor assessment correctly identified all but one positive patient. Conclusions: HCV testing based on clinician-led risk assessment is an effective approach to HCV screening.

Additional keywords: body piercing, injecting drug use, HCV, risk assessment, tattoos, testing policy.


Acknowledgements

The authors would like to thank Ruth Primrose and other Canberra Sexual Health Centre staff for their support during the data collection phase of the study. We would also like to thank the anonymous reviewers for their constructive comments.


References


[1] Balogun MA,  Ramsay ME,  Parry JV,  Donovan L,  Andrews NJ,  Newham JA, et al. A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection. Sex Transm Infect 2003 ; 79 301–6.
Crossref | GoogleScholarGoogle Scholar | PubMed | [verified 4 December 2007]

[8] Winstock AR,  Anderson CM,  Sheridan J. National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia. Med J Aust 2006 ; 184 560–2.
PubMed | [verified 4 December 2007]

[15] Communicable Diseases Australia. National Notifiable Diseases Surveillance System. Canberra: Australian Commonwealth Government; 2007. Available online at: http://www9.health.gov.au/cda/Source/CDA-index.cfm [verified 4 December 2007]

[16] Schroter M,  Schafer P,  Zollner B,  Polywka S,  Laufs R,  Feucht HH. Strategies for reliable diagnosis of hepatitis C infection: the need for a serological confirmatory assay. J Med Virol 2001 ; 64 320–4.
Crossref | GoogleScholarGoogle Scholar | PubMed | [verified 4 December 2007]